Brought to you by 
St. Jude exercises option for Spinal Modulation; pays $175mm plus earn-outs
21 Aug 2020
Executive Summary
St. Jude Medical Inc. exercised its exclusive option to buy Spinal Modulation Inc. and will pay $175mm, plus earn-outs upon FDA approval of the Axium intraspinal neurostimulator system and achievement of certain revenue goals.
Deal Industry
- Medical Devices
-
Medical Devices
- Implantable Devices
Deal Status
- Final
Deal Type
-
Acquisition
- Includes Earnout
- Partial Acquisition
- Payment Includes Cash
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
St. Jude exercises option for Spinal Modulation; pays $175mm plus earn-outs
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice